Search

Filters
Clear All
  • 21
  • 55
  • 1
  • 679

Phase

  • 1
  • 16
  • 16
  • 59
  • 8
  • 79
  • 5
  • 554
  • 669
  • 302
  • 733
  • 23

Found 756 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

K
Kenneth Lim
18 years - 100 years
All genders
Interventional
What is the purpose of this study?The purpose of this study is to gather information on cardiovascular changes in hemodialysis patients, both home-hemo and conventional hemo-dialysis. Research indicates that cardiovascular disease remains the leading cause of death among patients with chronic kidney disease (CKD) and those on dialysis.THIS STUDY IS …
S
Sushil Gupta
100 years or below
All genders
Observational
What is the purpose of this study?The purpose of the BIGKiDs Biobank study is to help discover genomic factors that cause or contribute to kidney disease and related disorders in children. Samples and data will also be shared with other researchers at Boston Children’s Hospital (BCH) as well as with …
J
Jan Szatkowski
18 years - 100 years
All genders
Observational
What is the purpose of this study?This is an Observational Device Registry Study of CERAMENT G in normal use in accordance with the IFU. A Device Registry is a form of observational study that concerns the performance of a device in normal use. It is intended to collect data that …
J
Jamie L. Bradbury, MD
18 years - 65 years
All genders
Interventional
This study investigates the effects of an investigational medication on recovery from traumatic brain injury (TBI). Traumatic brain injury occurs when an external force injures the brain, often leading to long-term complications or death. The study aims to compare recovery outcomes between participants receiving investigational medications and those receiving a …
T
Tarah Ballinger, MD
40 years or below
Female
Phase 3
This study investigates the effects of an investigational medication on protecting the ovaries in young females with cancer who are receiving chemotherapy. Chemotherapy, particularly with alkylating agents, can harm the ovaries, making it hard to get pregnant later. The investigational medication may help by slowing down the ovaries during chemotherapy, …
R
Rohan Maniar
18 years - 100 years
All genders
Phase 2
What is the purpose of this study?This phase II Expanded Lung-MAP treatment trial tests how well amivantamab-subcutaneous (SC) works in treating patients patients with MET amplification non-small cell lung cancer. Amivantamab-SC is a drug that reduces extra copies of the MET gene, a change present in your tumor. Giving amivantamab-SC …
M
Michael Koch, MD
45 years - 100 years
Male
This study investigates the use of an investigational device for men who have stress urinary incontinence after having their prostate removed because of cancer. Stress urinary incontinence happens when activities like coughing or lifting cause urine to leak. The purpose of this study is to see if the device is …
C
Cary Mariash, MD
18 years - 75 years
All genders
Phase 2/3
Interventional
This is a study to assess the efficacy, safety, and tolerability of IMVT-1402 in adult participants with Graves' disease (GD) who are hyperthyroid despite antithyroid drug (ATD) treatment.The primary objective of this study is to evaluate the efficacy of IMVT-1402 versus placebo as assessed by T3 (total triiodothyronine [T3] or …
K
Kathy Miller, MD
18 years - 100 years
All genders
Phase 3
This study investigates the use of low-dose tamoxifen compared to usual hormonal therapy in treating post-menopausal women with hormone-positive, HER2 negative early-stage breast cancer. Hormone-positive breast cancer is a type of cancer that grows in response to hormones like estrogen. HER2 negative means the cancer does not have higher levels …
D
Dan Foti
18 years - 30 years
Accepts healthy volunteer
All genders
The PACER Lab at Purdue University is looking for volunteers age 18-30 years old for a study on PFASand brain activity (PI: Dr. Dan Foti, IRB protocol IRB-2023-1271).
581 - 590 of 756